Search Results
Test Catalog
FSCPR - Overview: Scleroderma Comprehensive Profile
Scleroderma Comprehensive Profile
SFX - Overview: Protein S Activity, Plasma
Second-order testing for diagnosis of congenital or acquired protein S deficiency, ie, as an adjunct to initial testing based on results of protein S antigen assay (free protein S antigen, with or without total protein S antigen assay)...
MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine
Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients
RAVU - Overview: Ravulizumab, Serum
Assessing the response to ravulizumab therapy Assessing the need for dose escalation Evaluating the potential for dose deescalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
TSTIM - Overview: Targeted Stimulant Screen, Random, Urine
Aiding in the determination of compliance or identify illicit stimulant drug use This test is not intended for use in employment-related testing.
TSPU - Overview: Targeted Stimulant Screen, Random, Urine
Determining compliance or identifying illicit stimulant drug use This test is not intended for employment-related testing.
FMMPP - Overview: MyoMarker 3 Plus Profile
MyoMarker 3 Plus Profile
PSF - Overview: Protein S Antigen, Free, Plasma
As part of an investigation of patients with a history of thrombosis
PTNT - Overview: Prothrombin G20210A Mutation, Blood
Patients with clinically suspected thrombophilia Determination of the duration of anticoagulation therapy of venous thromboembolism patients Screening for women contemplating hormone therapy
AMPHM - Overview: Amphetamine-Type Stimulants Confirmation, Meconium
Detecting in utero exposure to amphetamine-type stimulants up to 5 months before birth
Detecting in utero drug exposure to marijuana (tetrahydrocannabinol) up to 5 months before birth
COKEM - Overview: Cocaine and Metabolites Confirmation, Meconium
Detecting in utero drug exposure up to 5 months before birth
PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium
Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth
ECMP - Overview: Eculizumab Monitoring Panel, Serum
Monitoring of complement blockage by eculizumab Assessing the response to eculizumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy in remission...
CORTO - Overview: Cortisol, Free and Total, Serum
Assessment of cortisol status in cases where there is known or a suspected abnormality in cortisol-binding proteins or albumin Assessment of adrenal function in the critically ill or stressed patient, thus preventing unnecessary use of...
CAH21 - Overview: Congenital Adrenal Hyperplasia (CAH) Profile for 21-Hydroxylase Deficiency, Serum
Preferred screening test for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency Part of a battery of tests to evaluate women with hirsutism or infertility, which can result from adult-onset CAH
AMPMX - Overview: Amphetamine-Type Stimulants Confirmation, Chain of Custody, Meconium
Detecting in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by...
APOLB - Overview: Apolipoprotein B, Serum
Assessment of cardiovascular risk Follow-up studies in individuals with basic lipid measures inconsistent with risk factors or clinical presentation Definitive studies of cardiac risk factors in individuals with significant family...
SALCT - Overview: Cortisol, Saliva
Screening for Cushing syndrome Diagnosis of Cushing syndrome in patients presenting with symptoms or signs suggestive of the disease
PCPMX - Overview: Phencyclidine (PCP) Confirmation, Chain of Custody, Meconium
Detection of in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen...
Detecting in utero drug exposure to marijuana (tetrahydrocannabinol) up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the...
6MAMM - Overview: 6-Monoacetylmorphine (6-MAM), Confirmation, Meconium
Detection of in utero heroin exposure up to 5 months before birth
CPAPS - Overview: Conventional Smear-Screen, Varies
Screening for cervical carcinoma and a number of infections of the female genital tract including human papillomavirus, herpes, Candida, and Trichomonas
CPAPD - Overview: Conventional Smear-Diagnostic, Varies
Screening for cervical carcinoma and a number of infections of the female genital tract including human papillomavirus, herpes, Candida, and Trichomonas
PSTF - Overview: Protein S Antigen, Plasma
Investigation of patients with a history of thrombosis
COKMX - Overview: Cocaine and Metabolite Confirmation, Chain of Custody, Meconium
Detecting in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by...
DASM5 - Overview: Drugs of Abuse Screen, Meconium 5
Identifying amphetamines (and methamphetamines), opiates, phencyclidine, as well as metabolites of cocaine and marijuana in meconium specimens
MAMMX - Overview: 6-Monoacetylmorphine (6-MAM) Confirmation, Chain of Custody, Meconium
Detecting in utero heroin exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen...
DASM4 - Overview: Drugs of Abuse Screen, Meconium 4
Identifying amphetamines (and methamphetamines), opiates, as well as metabolites of cocaine and marijuana in meconium specimens
ECULI - Overview: Eculizumab, Serum
Assessing the response to eculizumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
GUS - Overview: Guselkumab, Serum
Assessing the response to guselkumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy Monitoring patients who need to be above a certain guselkumab...
BLWX - Overview: Walnut-Food Components, IgE, Serum
Evaluation of patients with suspected walnut-food allergy to one of 2 walnut-food components
DTHPV - Overview: ThinPrep Diagnostic with Human Papillomavirus (HPV) Reflex, Varies
Management and triage of patients aged 21 years or older with abnormal Papanicolaou (Pap) results Diagnostic test for detection of human papillomavirus (HPV) high-risk genotypes associated with the development of cervical cancer Results...
NUTHR - Overview: Hazelnut-Food, IgE with Reflex to Hazelnut-Food Components, IgE, Serum
Evaluation of patients with suspected hazelnut-food allergy
NUTHX - Overview: Hazelnut-Food Components, IgE, Serum
Evaluation of patients with suspected hazelnut-food allergy to one of 4 hazelnut-food components
ASPAG - Overview: Aspergillus (Galactomannan) Antigen, Serum
Aiding in the diagnosis of invasive aspergillosis Assessing response to therapy
DSM5X - Overview: Drugs of Abuse Screen 5, Chain of Custody, Meconium
Identifying amphetamines (and methamphetamines), opiates, and phencyclidine, as well as metabolites of cocaine and marijuana in meconium specimens Chain of custody is required whenever the results of testing could be used in a court of...
DSM4X - Overview: Drugs of Abuse Screen 4, Chain of Custody, Meconium
Identifying amphetamines (and methamphetamines) and opiates, as well as metabolites of cocaine and marijuana in meconium specimen Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is...
RISA - Overview: Risankizumab, Serum
Assessing the response to risankizumab therapy Assessing the need for dose escalation Evaluating potential changes or discontinuation of therapy Monitoring patients who need to be above a certain risankizumab concentration to improve the...
BLWRF - Overview: Walnut-Food, IgE, with Reflex to Walnut-Food Components, IgE, Serum
Evaluation of patients with suspected walnut-food allergy
CINP - Overview: Cortisol, Mass Spectrometry, Serum
Second-order testing when cortisol measurement by immunoassay (eg, CORT / Cortisol, Serum) gives results that are not consistent with clinical symptoms, or if patients are known to, or suspected of, taking exogenous synthetic steroids...
CASHX - Overview: Cashew Component, IgE, Serum
Evaluation of patients with suspected cashew allergy to component Ana o 3
GALTP - Overview: Galactose-1-Phosphate Uridyltransferase Biochemical Phenotyping, Erythrocytes
Determining the biochemical phenotype for galactosemia when enzymatic and molecular results are incongruent
CASHR - Overview: Cashew, IgE with Reflex to Cashew Component, IgE, Serum
Evaluation of patients with suspected cashew allergy
RAVMP - Overview: Ravulizumab Monitoring Panel, Serum
Monitoring of complement blockage by ravulizumab Assessing the response to ravulizumab therapy Assessing the need for dose escalation Evaluating the potential for dose deescalation or discontinuation of therapy in remission...
CFMP - Overview: Cystic Fibrosis, CFTR Gene, Variant Panel, Varies
Confirmation of a clinical diagnosis of cystic fibrosis Reproductive risk refinement via carrier screening for individuals in the general population Reproductive risk refinement via carrier screening for individuals with a family history...
INFXP - Overview: Infliximab Quantitation with Antibodies to Infliximab, Serum
Trough level quantitation for evaluation of patients undergoing therapy with infliximab for proactive or reactive therapeutic drug monitoring.
DOGPF - Overview: Dog Dander, IgE, with Reflex to Dog Dander Components, IgE, Serum
Evaluating patients with suspected dog dander allergy
NONCM - Overview: Neuro-Oncology Gene Panel, Mutations Only, Tumor
Identifying mutations that may support a diagnosis or help determine prognosis for patients with central nervous system tumors Identifying specific mutations within genes known to be associated with response or resistance to specific...
NONCP - Overview: Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor
Identifying mutations and rearrangements that may support a diagnosis or help determine prognosis for patients with CNS tumors Identifying specific mutations and rearrangements within genes known to be associated with response or...
Site Search
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme...
webinar on implementation of high-sensitivity troponin I assay - Insights
Cardiovascular Diseases, will be presenting a webinar on the implementation of a high-sensitivity troponin I assay. The webinar will be held February 13 from 1:00-2:00 p.m. eastern....
Should I Stay or Should I Go? - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., and Rondell Graham, M.B.B.S., delve into the critical decisions involved in contemplating a role on the staff at the institution where you receive your training.
often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
inform novel treatments for kidney stones - Part I - Insights
A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.